Ligand validation:6YG4

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6YG4_EDO_A_502	50%	98%	0.137	0.888	0.11	0.17	-	-	0	0	100%	1
6YG4_EDO_A_503	45%	97%	0.187	0.918	0.19	0.14	-	-	0	0	100%	1
6YG4_EDO_A_506	31%	97%	0.173	0.839	0.12	0.18	-	-	0	0	100%	1
6YG4_EDO_A_505	22%	98%	0.179	0.796	0.11	0.15	-	-	0	0	100%	1
6YG4_EDO_A_501	17%	97%	0.293	0.876	0.1	0.23	-	-	0	0	100%	1
6YG4_EDO_A_504	13%	91%	0.206	0.74	0.26	0.3	-	-	0	0	100%	1
6YG1_EDO_B_505	69%	83%	0.133	0.947	0.41	0.37	-	-	0	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1
3G7R_EDO_B_961	100%	85%	0.035	0.988	0.45	0.3	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.